The International Association of Biomedical Sciences Forum (IABS Forum-2023) was successfully concluded on December 7th and 8th, 2023, at the Irvine Multicultural Center in the United States. The forum witnessed the enthusiastic participation of nearly 200 neuroscience experts and scholars from around the world.
Group photo of participants at the IABS FORUM-2023.
Focused on neurodegenerative diseases, primarily Alzheimer’s disease, the forum invited 30 top scientists in the field as keynote speakers. The event aimed to delve into groundbreaking advancements in the field of neurodegenerative diseases, providing an academic platform for exchange and collaboration, strengthening the link between academia and industry, promoting the development of novel therapies, and exploring new treatment methods for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases. This conference holds significant importance in advancing research and innovation in neuroscience. The forum was jointly hosted by Professor Jijun Hao, Professor Lei Xu, and Dr. Shanghao Li.
Professors Jijun Hao, Lei Xu, and Dr. Shanghao Li serve as moderators for the IABS FORUM-2023.
Dr. Yongtian Li, the founder and chairman of the International Association of Biomedical Sciences, expressed in his opening speech, “Today, we gather here with great enthusiasm, dedicated to innovative strategies against neurodegenerative diseases, primarily Alzheimer’s disease. Under the theme of ‘New Concepts in the Treatment of Neurodegenerative Diseases,’ we have invited distinguished speakers, including Nobel laureate Dr. Thomas Südhof, along with 30 other top experts in the field, to share their expertise and experiences and engage in in-depth discussions on cutting-edge research and new ideas.”
Founder of the International Association of Biomedical Sciences, Yongtian Li, delivers the opening speech at the forum.
Dr. Yongtian Li continued, “During these two days of the event, our shared goal is to unite leading scientists in the field of neuroscience to advance our understanding of neurodegenerative diseases such as Alzheimer’s and Parkinson’s, and to seek solutions.”
Dr. Thomas Südhof, Nobel laureate and neuroscientist from Stanford University, delivers the keynote speech.
At this forum, Dr. Thomas Südhof, the 2013 Nobel laureate and a neuroscientist from Stanford University, delivered a keynote speech entitled “Towards A Cell Biology of Alzheimer’s Disease”. Alzheimer’s disease has a prevalence rate of 11% among Americans over the age of 65. It is a neurodegenerative disease characterized by dysfunction in various cell types, which leads to neuronal death. Research suggests that synaptic dysfunction plays a critical role in the occurrence of Alzheimer’s disease.
Professor Caleb Finch from the USC Leonard Davis School of Gerontology serves as the session chair and presides over the conference at the IABS FORUM-2023.
Professor Jing Liang, the developer of “Smarto One” for dementia and a professor of clinical pharmacology at the University of Southern California, delivers a speech.
Professor Michel Baudry from Western University delivers a speech at the IABS FORUM-2023.
Professor Russell Swerdlow from the University of Kansas delivers a speech and then proceeds to answer questions from attendees at the conference.
Professor Nicolas Bazan from Louisiana State University delivers a speech at the IABS FORUM-2023.
Professor Donald Moss from the University of Texas delivers a speech at the IABS FORUM-2023.
Professor Xiangmin Xu from the University of California, Irvine, delivers a speech at the IABS FORUM-2023.
Professor Luigi Puglielli from the University of Wisconsin-Madison delivers a speech at the IABS FORUM-2023.
During the IABS FORUM-2023, participants eagerly engage in discussions and actively share their insights.
Other speakers included Professor David Morgan, the Director of the Alzheimer’s Disease Consortium at CHM, and the Michigan State University Translational Neuroscience Foundation; Professor Jing Liang, the developer of “Smarto One” for dementia and a professor of clinical pharmacology at the University of Southern California; Professor Caleb Finch, a professor of anthropology, neurobiology, physiology, and neurology at the USC Leonard Davis School of Gerontology; Professor Frank LaFerla, the Dean of the School of Biological Sciences and the Chair of the Department of Neurobiology and Behavior at the University of California, Irvine; Professor Xiangmin Xu, a professor of pharmacology and neurobiology at the University of California, Irvine; Professor Michel Baudry from Western University of Health Sciences (WUHS), Professor Giulio Maria Pasinetti from Mount Sinai School of Medicine (MSC), and Professor Khalid Iqbal, Chief Senior Scientist at the New York State Institute for Alzheimer’s Disease Neurobiology. These renowned experts in neurology and geriatric medicine from around the world shared and discussed cutting-edge research findings, technological innovations, and treatment methods in the fields of Alzheimer’s disease, Parkinson’s disease, and aging at the forum.
Nobel laureate Thomas Sudhof conducts media interviews during the IABS FORUM-2023.
Dr. Südhof, a Nobel laureate and neuroscientist, expressed in an interview with this newspaper that although scientists have conducted extensive research on Alzheimer’s disease and made significant progress, there is still no cure or definitive treatment due to the lack of a precise understanding of the underlying causes. He emphasized the need for continued dedication of more efforts, time, and resources to further address this issue.
Dr. William Shankle from the Alzheimer’s Specialty Clinic delivers a speech at the IABS FORUM-2023.
The Secretary-General of the International Association of Biomedical Sciences, Jijun Hao, presents a crystal appreciation plaque to Giulio Pasinetti, the chair of the organizing committee.
Dr. Li Yongtian and Dr. Sandy Cui from the IABS present a crystal appreciation plaque to Nobel laureate Thomas Sudhof.
This forum was organized by the International Association of Biomedical Sciences (IABS) and co-hosted by the School of Pharmacy at the University of Southern California (USC), with sponsorship from institutions such as Western University of Health Sciences (WUHS) and GC Natural. Participants in this event included university professors, scientists, entrepreneurs, drug developers, clinical doctors, as well as acupuncture and traditional Chinese medicine practitioners in the United States. Co-organizers included the Chinese Association for Science and Technology in the USA, the Irvine Multicultural Services Center, and the Alliance of Associations of International Students in the USA. In addition, strong support was received from organizations such as the Southern California Chinese Engineers Association, the Association of Chinese Professors and Scholars in the USA, the Southern California Chinese Alumni Association Alliance, the Southern California Traditional Chinese Medicine Education Center, the Bailing American Federation, the All-China Zhejiang Entrepreneurs Federation in the USA, the US-China Entrepreneurs Association, the Chicago Association of Professors and Scholars, the Chinese Expert Association in the USA, Wei She, UCTV, AMTV, Micro Shot, Yinglong Culture Media, and Sino-US Times.
The successful hosting of the IABS Forum-2023 has not only greatly promoted the development of neuroscience but also built a bridge for international academic cooperation. Looking towards the future, scientists will continue to work hard and dedicate themselves to tackling major challenges such as neurodegenerative diseases, making further contributions to human health.